Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,798 | 21,095 | 26,617 | 21,738 | 11,315 |
| Receivables | 59,716 | 48,530 | 40,872 | 36,219 | 29,207 |
| Inventories | 21,260 | 25,099 | 18,165 | 19,357 | 16,240 |
| TOTAL | $112,107 | $96,790 | $85,794 | $77,861 | $57,739 |
| Non-Current Assets | |||||
| PPE Net | 10,181 | 10,035 | 10,098 | 10,270 | 10,327 |
| Intangibles | 4,791 | 5,638 | 5,638 | 5,638 | 5,638 |
| Other Non-Current Assets | 11,211 | 13,950 | 15,718 | 17,571 | 22,683 |
| TOTAL | $26,183 | $29,623 | $31,454 | $33,478 | $38,648 |
| Total Assets | $138,290 | $126,413 | $117,248 | $111,339 | $96,388 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 229 | 228 | 231 | 231 | 4,247 |
| Accounts payable and accrued liabilities | 6,053 | 6,522 | 3,425 | 5,089 | 2,958 |
| Accrued Expenses | 10,194 | 5,548 | 6,152 | 4,582 | 3,795 |
| TOTAL | $17,392 | $13,187 | $10,674 | $10,763 | $11,840 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,805 | 2,825 | 2,845 | 3,014 | 3,033 |
| Deferred Revenues | N/A | N/A | N/A | 2 | 6 |
| Other Non-Current Liabilities | 18,359 | 29,129 | 41,082 | 48,733 | 26,751 |
| TOTAL | $22,015 | $32,911 | $44,989 | $52,894 | $31,032 |
| Total Liabilities | $39,407 | $46,099 | $55,663 | $63,657 | $42,873 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,077,196 | 1,076,996 | 1,074,496 | 1,070,963 | 1,068,463 |
| Common Shares | 1,077 | 1,075 | 1,074 | 1,069 | 1,069 |
| Retained earnings | -75,831 | -94,292 | -112,886 | -126,589 | -120,704 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $98,883 | $80,314 | $61,585 | $47,683 | $53,515 |
| Total Liabilities And Equity | $138,290 | $126,413 | $117,248 | $111,339 | $96,388 |